XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
Common stock
Additional paid-in capital
Statutory reserve
Accumulated Deficts
Accumulative other comprehensive income
Non-controlling interests
Total
Balance at Dec. 31, 2023 $ 1,783 $ 233,907,049 $ 98,357 $ (185,929,662) $ (4,094,276) $ (1,568,207) $ 42,415,044
Balance (in Shares) at Dec. 31, 2023 1,783,487            
Net income (loss) from continuing operation (4,150,649) (4,150,649)
Net loss from discontinued operations (1,582,969) (34,454) (1,617,423)
Issuance of common stocks-cash $ 215 2,580,428 2,580,643
Issuance of common stocks-cash (in Shares) 215,054            
Disposition of discontinued operation 645,437 47,453 692,890
Foreign currency translation adjustment (208,345) (208,345)
Balance at Jun. 30, 2024 $ 1,998 236,487,477 98,357 (191,017,843) (4,255,168) (1,602,661) 39,712,160
Balance (in Shares) at Jun. 30, 2024 1,998,541            
Balance at Mar. 31, 2024 $ 1,998 236,487,477 98,357 (189,256,870) (4,141,900) (1,564,628) 41,624,434
Balance (in Shares) at Mar. 31, 2024 1,998,541            
Net income (loss) from continuing operation (809,159) (809,159)
Disposition of discontinued operation (951,814) 135,375 (38,033) (854,472)
Foreign currency translation adjustment (248,643) (248,643)
Balance at Jun. 30, 2024 $ 1,998 236,487,477 98,357 (191,017,843) (4,255,168) (1,602,661) 39,712,160
Balance (in Shares) at Jun. 30, 2024 1,998,541            
Balance at Dec. 31, 2024 $ 2,447 237,496,176 98,357 (218,885,534) (4,248,561) (1,866,066) $ 12,596,819
Balance (in Shares) at Dec. 31, 2024 2,447,084           2,447,084
Issuance of common stocks-conversion of debt $ 121 204,737 $ 204,858
Issuance of common stocks-conversion of debt (in Shares) 121,205            
Effect to rounding fractional shares into whole shares upon reverse stock split $ 43 (43)
Effect to rounding fractional shares into whole shares upon reverse stock split (in Shares) 42,481           4,211
Share-based payments-omnibus equity plan $ 500 1,084,500 $ 1,085,000
Share-based payments-omnibus equity plan (in Shares) 500,000            
Pending Equity Settlement 1,688,964 1,688,964
Net income (loss) from continuing operation (29,093,624) (29,093,624)
Disposition of discontinued operation 26,372,056 (179,909) 1,866,066 28,058,213
Foreign currency translation adjustment 7,459 7,459
Balance at Jun. 30, 2025 $ 3,111 240,474,334 98,357 (221,607,102) (4,421,011) $ 14,547,689
Balance (in Shares) at Jun. 30, 2025 3,110,770           3,110,770
Balance at Mar. 31, 2025 $ 3,009 238,721,272 98,357 (223,458,882) (4,441,655) $ 10,922,101
Balance (in Shares) at Mar. 31, 2025 3,009,289            
Issuance of common stocks-conversion of debt $ 60 64,140 64,200
Issuance of common stocks-conversion of debt (in Shares) 60,000            
Effect to rounding fractional shares into whole shares upon reverse stock split $ 42 (42)
Effect to rounding fractional shares into whole shares upon reverse stock split (in Shares) 41,481            
Pending Equity Settlement 1,688,964 1,688,964
Net income (loss) from continuing operation 1,851,780 1,851,780
Foreign currency translation adjustment 20,644 20,644
Balance at Jun. 30, 2025 $ 3,111 $ 240,474,334 $ 98,357 $ (221,607,102) $ (4,421,011) $ 14,547,689
Balance (in Shares) at Jun. 30, 2025 3,110,770           3,110,770